There were no statistically significant differences in the ratios of Gal-1/IL-1β, Gal-1/IL-6, Gal-1/IL-23, Gal-1/IL-33 and Gal-1/IL-10 as well as IL-10/IL-1β, IL-10/IL-6, IL-10/IL-23, IL-10/IL-33 between defined groups of COVID-19 patients (Fig. 2). This evidence concerns the gene LGALS1 and COVID-19.